4th Quarter - Report
TARPLIN STRATEGIES LLC for GENENTECH, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Government reimbursement for biotherapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD JOSEPH TARPLIN | and Families |
Health Issues HCR
General health care reform issues. Government reimbursement for biotherapeutics. Comparative effectiveness research. Legislative and regulatory issues involved in FDA approval of follow-on biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD JOSEPH TARPLIN | and Families |
Pharmacy PHA
Legislative and regulatory issues involved in FDA approval of follow-on biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD JOSEPH TARPLIN | — |
Medical/Disease Research/Clinical Labs MED
Comparative effectiveness research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD JOSEPH TARPLIN | and Families |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.